Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Heron Therapeutics, Inc. (HRTX) vs Nomad Power Solutions, Inc. (NMAD)

Heron Therapeutics, Inc. and Nomad Power Solutions, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and Nomad Power Solutions, Inc. are of similar size ($58.5M and $57.0M). Nomad Power Solutions, Inc. has the higher net margin (0.00% vs −22.5%) and the lower return on invested capital (−40.4% vs −6.35%). Across the 13 metrics below, Nomad Power Solutions, Inc. leads on 9 and Heron Therapeutics, Inc. on 4.

Valuation

Metric HRTX NMAD Biotechnology median
P/E n/m n/m 7.88
P/S 0.38 n/m 11.47
P/B 9.75 1.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.04 n/m 10.73
Earnings yield (63.33%) (27.93%) (28.84%)
Free cash flow yield (21.17%) (11.31%) (23.03%)

Profitability

Metric HRTX NMAD Biotechnology median
Gross margin 70.07% — 65.16%
Operating margin (7.19%) 0.00% 0.00%
Net margin (22.52%) 0.00% 0.00%
Free cash flow margin (8.00%) 0.00% 0.00%
Return on equity 318.21% (68.04%) (57.72%)
Return on assets (14.06%) (62.67%) (49.22%)
Return on invested capital (6.35%) (40.41%) 0.00%

Growth

Metric HRTX NMAD Biotechnology median
Revenue growth (TTM) 0.99% — 5.64%
EPS growth (last fiscal year) (33.33%) 20.75% —
Revenue growth, 5-year CAGR 11.81% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX NMAD Biotechnology median
Debt to equity 20.65 0.00 0.00
Current ratio 2.49 12.87 4.73
Net debt to EBITDA (643.88) 1.00 0.96

Dividend

Metric HRTX NMAD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HRTX NMAD Biotechnology median
Market cap 56.96m 58.45m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack